Authors:
Bouba, I
Koptides, M
Mean, R
Costi, CE
Demetriou, K
Georgiou, I
Pierides, A
Siamopoulos, K
Deltas, CC
Citation: I. Bouba et al., Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families, EUR J HUM G, 9(9), 2001, pp. 677-684
Authors:
Briasoulis, E
Judson, I
Pavlidis, N
Beale, P
Wanders, J
Groot, Y
Veerman, G
Schuessler, M
Niebch, G
Siamopoulos, K
Tzamakou, E
Rammou, D
Wolf, L
Walker, R
Hanauske, A
Citation: E. Briasoulis et al., Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Researchand Treatment of Cancer Early Clinical Studies Group, J CL ONCOL, 18(20), 2000, pp. 3535-3544
Authors:
Stamatelatos, IE
Katopodis, K
Bersos, Y
Kalef-Ezra, JA
Lefkopoulos, G
Siamopoulos, K
Citation: Ie. Stamatelatos et al., Serum aluminum determination by instrumental neutron activation analysis in long-term haemodialysis patients, J RAD NUCL, 241(3), 1999, pp. 483-486
Authors:
Christou, L
Hatzimichael, EC
Sotsiou-Candila, F
Siamopoulos, K
Bourantas, KL
Citation: L. Christou et al., A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival, ACT HAEMAT, 101(4), 1999, pp. 202-205